<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/89E6D9CB-DAF8-40A2-A9EF-B330A5A7FC24"><gtr:id>89E6D9CB-DAF8-40A2-A9EF-B330A5A7FC24</gtr:id><gtr:name>Open University</gtr:name><gtr:department>Mathematics &amp; Statistics</gtr:department><gtr:address><gtr:line1>Walton Hall</gtr:line1><gtr:line2>Walton</gtr:line2><gtr:line4>Milton Keynes</gtr:line4><gtr:line5>Buckinghamshire</gtr:line5><gtr:postCode>MK7 6AA</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/89E6D9CB-DAF8-40A2-A9EF-B330A5A7FC24"><gtr:id>89E6D9CB-DAF8-40A2-A9EF-B330A5A7FC24</gtr:id><gtr:name>Open University</gtr:name><gtr:address><gtr:line1>Walton Hall</gtr:line1><gtr:line2>Walton</gtr:line2><gtr:line4>Milton Keynes</gtr:line4><gtr:line5>Buckinghamshire</gtr:line5><gtr:postCode>MK7 6AA</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/B32BA7F8-02C4-429E-A7E7-C21839CDF00B"><gtr:id>B32BA7F8-02C4-429E-A7E7-C21839CDF00B</gtr:id><gtr:firstName>Conor</gtr:firstName><gtr:otherNames>Patrick</gtr:otherNames><gtr:surname>Farrington</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0501690"><gtr:id>8DC35E45-474B-40C8-A9A5-A3B09E65CE9C</gtr:id><gtr:title>Prospective surveillance of vaccine safety by case series analysis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0501690</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>70259</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>PHE - Sequential methods</gtr:description><gtr:id>04D36ACC-E27E-4B8D-A705-342EB0D0D4EE</gtr:id><gtr:impact>Publications and applications.</gtr:impact><gtr:outcomeId>FCF06D1A090-1</gtr:outcomeId><gtr:partnerContribution>Publications and applications</gtr:partnerContribution><gtr:piContribution>Collaborative research and publication.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute of Health and Medical Research (INSERM)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>INSERM - Surveillance of vaccine safety</gtr:description><gtr:id>0878E4C5-73EF-4282-91AC-751171FDB0CE</gtr:id><gtr:impact>Development of new vaccine safety surveillance methods in France</gtr:impact><gtr:outcomeId>936BF1B39A0-1</gtr:outcomeId><gtr:partnerContribution>Publications and applications</gtr:partnerContribution><gtr:piContribution>Publications and applications</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>72000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>iMi</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>1477C3D4-BF1E-4BC7-A403-ADCB73CB529A</gtr:id><gtr:outcomeId>Sr1XwrMZPQQ</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Sequential implementation of the self-controlled case series method</gtr:description><gtr:id>B3A28EB3-2480-47A3-95B8-0B16D7CCC2F6</gtr:id><gtr:impact>New methods for pharmacovigilance, notably in vaccine surveillance</gtr:impact><gtr:outcomeId>5447d7a0c7cfb1.96495544</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Sequential case series methods</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>79104398-7082-4D2C-A991-3207F347A5F2</gtr:id><gtr:title>Monitoring vaccine safety using case series cumulative sum charts.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35d237e79101fe812d9aef52c2414f50"><gtr:id>35d237e79101fe812d9aef52c2414f50</gtr:id><gtr:otherNames>Musonda P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>CF11379C3BE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2EF57F2A-4E83-4C07-916E-8B3E3CD46CF6</gtr:id><gtr:title>The methodology of self-controlled case series studies.</gtr:title><gtr:parentPublicationTitle>Statistical methods in medical research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c26558a1abc6432dde9934f05987b9c5"><gtr:id>c26558a1abc6432dde9934f05987b9c5</gtr:id><gtr:otherNames>Whitaker HJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0962-2802</gtr:issn><gtr:outcomeId>6C02EE79B07</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A8A1B79-DA74-4DE9-8EFC-8960089CE293</gtr:id><gtr:title>Sequential case series analysis for pharmacovigilance</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Statistical Society: Series A (Statistics in Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1503320a7184ca9a494471a36cca5d26"><gtr:id>1503320a7184ca9a494471a36cca5d26</gtr:id><gtr:otherNames>Hocine M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:outcomeId>doi_53d06706797acd73</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0501690</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>90487A08-C473-4CEB-B6D9-011A74AD06CF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>8.4  Research design and methodologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>